Latest update: 09/06/2011
Pharma-scandals: two drugs, two different stories
Are all pharmaceuticals companies equal before French regulators? In this edition of Beyond Business we take a look at two different case studies, and two different drugs. Both were given to diabetics, and both were linked to increased rates of heart disease. However, only one of the drugs attracted widespread scrutiny and public attention.